Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

smartADHERE - Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation

NCT02996435 is registered in ClinicalTrials.gov with Janssen Scientific Affairs, LLC as lead sponsor.

NCT NCT02996435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02996435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
smartADHERE - Smartphones to Improve Rivaroxaban ADHEREnce in Atrial Fibrillation
Lead sponsor
Janssen Scientific Affairs, LLC
Phase
Phase 4
Overall status
Completed
Start date
December 21, 2016
Completion date
March 22, 2018
Enrollment
139 (actual)
Sites
25

Conditions

As the registry lists them; a condition with its own page is linked.

atrial fibrillation